The news from Monday was probably the most significant piece of news in the 10 year plus history of Viral Genetics Inc. (VRAL: PINK SHEETS) http://finance.yahoo.com/news/Viral-Genetics-HIVAIDS-bw-1583274227.html?x=0&.v=1 The question is how much money would it cost to conduct research and possible … Continue reading →

Professor Shattock research team at St. George’s University of London received a £10.7 million ($15.3 million) grant from the Grand Challenge for Global Health Initiative, co-funded by the Welcome Trust and the Bill & Melinda Gates Foundation. Shattock’s team also … Continue reading →

Big News on VRAL this morning…. Viral Genetics HIV/AIDS Compound Researched by London Team: http://finance.yahoo.com/news/Viral-Genetics-HIVAIDS-bw-1583274227.html?x=0&.v=1 Disclaimer: Institutional Analyst Inc., is an Investor Relations firm specializing in Investment Research and Investment Research Distribution. We specialize in getting (or creating) coverage for … Continue reading →

Last week 34% break out move to $.067, failed to materialize after encountering resistance in the $.06 area….the good news is the stock has pulled back to the $.05 support level were it has popped multiple times in the past … Continue reading →

A message to all members of 21ST CENTURY INVESTOR RELATIONS From Our Friends at the Biotech Stock Review, Thursday, 6/03/2010 http://www.biotechstockreview.com 1. Viral Genetics (VRAL) Mid-Year Update. A lot to read here. Even more, in-between-the-lines, to read . There is … Continue reading →

Expanding research capability Dr. Newell Texas A&M obtains $1,000,000 in new funding Patented Metabolic Disruption technology has potential to destroy cancer cells with additional potential bio fuel applications http://finance.yahoo.com/news/Viral-Genetics-Appoints-Dr-bw-2882412619.html?x=0&.v=1 http://21webir.com/stocks-and-sectors/disclaimer-for-viral-genetics-vral-pink-sheets/

After yesterday’s 34% move which probably indicates normal profit taking and a shakeout of the stock out of weak hands (traders). We would like to see the following to get a 2nd bullish confirmation signal. 1) $.06 area maintained and … Continue reading →

VRAL – could be a Bounce Play volume drying up stock off lower end of trading range. Just last Thursday up 20.00% after trading 2,327,720 shares to $$.06 Viral Genetics Appoints Dr. Baruch S. Blumberg to its Advisory Board SAN … Continue reading →

Nobel Laureate Dr. Baruch S. Blumberg, MD, PhD, has joined the advisory board of Viral Genetics, Inc., (Pink Sheets: VRAL). Dr. Blumberg will join fellow board members that include 2008 Nobel Prize recipient in medicine, Dr. Luc Montagnier, the co-discoverer … Continue reading →